Cargando…
A molecular docking study of EGCG and theaflavin digallate with the druggable targets of SARS-CoV-2
BACKGROUND: COVID-19 is an infectious disease caused by a novel positive-sense single-stranded RNA coronavirus called as SARS-CoV-2. This viral disease is known to infect the respiratory system, eventually leading to pneumonia. Crystallographic studies of the viral structure reveal its mechanism of...
Autores principales: | Mhatre, Susmit, Naik, Shivraj, Patravale, Vandana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682485/ https://www.ncbi.nlm.nih.gov/pubmed/33302163 http://dx.doi.org/10.1016/j.compbiomed.2020.104137 |
Ejemplares similares
-
Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review
por: Mhatre, Susmit, et al.
Publicado: (2021) -
Entry-inhibitory role of catechins against SARS-CoV-2 and its UK variant
por: Mhatre, Susmit, et al.
Publicado: (2021) -
Inhibition of SARS-CoV 3C-like Protease Activity by Theaflavin-3,3′-digallate (TF3)
por: Chen, Chia-Nan, et al.
Publicado: (2005) -
Computational molecular interaction between SARS-CoV-2 main protease and theaflavin digallate using free energy perturbation and molecular dynamics
por: Manish, Manish, et al.
Publicado: (2022) -
Antibacterial and Sporicidal Activity Evaluation of Theaflavin-3,3′-digallate
por: Yussof, Ayuni, et al.
Publicado: (2022)